• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示健康个体和心力衰竭患者循环 pro B 型利钠肽片段的高度异质性。

Exposing the High Heterogeneity of Circulating Pro B-Type Natriuretic Peptide Fragments in Healthy Individuals and Heart Failure Patients.

机构信息

Institute of Clinical Biochemistry, Innsbruck Medical University, Innsbruck , Austria.

Institute of Laboratory Medicine, Kantonsspital Aarau AG, Aarau, Switzerland.

出版信息

Clin Chem. 2020 Sep 1;66(9):1200-1209. doi: 10.1093/clinchem/hvaa130.

DOI:10.1093/clinchem/hvaa130
PMID:32797158
Abstract

BACKGROUND

The high molecular complexity of variably O-glycosylated and degraded pro B-type natriuretic peptide (proBNP) derived molecular forms challenges current immunoassays. Antibodies used show pronounced differences in cross-reactivities with these circulating fragments, which still need to be better characterized on a molecular level. To pave the way for advanced quantitative assays in the future, it is critical to fully understand these circulating forms.

METHODS

Plasma samples were collected from 8 heart failure (HF) patients and 2 healthy controls. NT-proBNP and proBNP were purified by immunoprecipitation and analyzed by nano-flow liquid chromatography coupled to high-resolution mass spectrometry. Fragments formed during proteolysis in solution digestion were distinguished from naturally occurring peptides by using an 18O stable isotope labeling strategy.

RESULTS

We detected 16 previously unknown circulating fragments of proBNP peptides (9 of which are located in the N-terminal and 7 in the C-terminal region), revealing a more advanced state of degradation than previously known. Two of these fragments are indicative of either unidentified processing modes or a far-reaching C-terminal degradation (or a combination thereof) of the precursor proBNP.

CONCLUSIONS

Our results further restrict ideal target epitopes for immunoassay antibodies and expand the current thinking of diversity, degradation, and processing of proBNP, as well as the distribution of circulating forms.

摘要

背景

具有可变 O-糖基化和降解的 B 型利钠肽原(proBNP)衍生分子形式的高分子复杂性给当前的免疫测定带来了挑战。所使用的抗体在与这些循环片段的交叉反应活性方面表现出明显的差异,这些差异仍需要在分子水平上更好地描述。为了为未来的先进定量测定铺平道路,充分了解这些循环形式至关重要。

方法

从 8 例心力衰竭(HF)患者和 2 例健康对照中采集血浆样本。NT-proBNP 和 proBNP 通过免疫沉淀进行纯化,并通过纳流液相色谱与高分辨率质谱联用进行分析。在溶液消化过程中形成的片段通过使用 18O 稳定同位素标记策略与天然存在的肽区分开来。

结果

我们检测到 proBNP 肽的 16 个以前未知的循环片段(其中 9 个位于 N 端,7 个位于 C 端区域),揭示了比以前已知的更先进的降解状态。其中两个片段表明存在未识别的加工模式或前体 proBNP 的广泛 C 端降解(或两者的组合)。

结论

我们的研究结果进一步限制了免疫测定抗体的理想靶抗原表位,并扩展了 proBNP 的多样性、降解和加工以及循环形式的分布的现有思维。

相似文献

1
Exposing the High Heterogeneity of Circulating Pro B-Type Natriuretic Peptide Fragments in Healthy Individuals and Heart Failure Patients.揭示健康个体和心力衰竭患者循环 pro B 型利钠肽片段的高度异质性。
Clin Chem. 2020 Sep 1;66(9):1200-1209. doi: 10.1093/clinchem/hvaa130.
2
Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.心力衰竭患者血浆中 N 末端 pro-B 型利钠肽原的循环片段。
Clin Chem. 2013 Oct;59(10):1523-31. doi: 10.1373/clinchem.2012.200204. Epub 2013 Jul 2.
3
Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.解析重度心力衰竭患者血浆中O-糖基化内源性(N端)B型利钠肽前体形式的分子复杂性
Clin Chem. 2017 Jan;63(1):359-368. doi: 10.1373/clinchem.2016.265397. Epub 2016 Nov 8.
4
Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.分子异质性对A 型和B 型利钠肽循环N 端片段的测量有重大影响。
Clin Chem. 2004 Sep;50(9):1576-88. doi: 10.1373/clinchem.2004.032490. Epub 2004 Jul 20.
5
Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure.重度心力衰竭患者中proBNP和NT-proBNP循环形式的分析。
Clin Chem. 2008 May;54(5):858-65. doi: 10.1373/clinchem.2007.090266. Epub 2008 Mar 13.
6
Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.B型利钠肽(BNP)和BNP前体(proBNP)对中性内肽酶切割的不同敏感性:N端部分至关重要。
Clin Chem. 2016 Apr;62(4):617-22. doi: 10.1373/clinchem.2016.254524. Epub 2016 Feb 10.
7
ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.苏氨酸 71 位未糖基化的脑利钠肽(ProBNP)在心力衰竭患者中随肥胖而减少。
Clin Chem. 2019 Sep;65(9):1115-1124. doi: 10.1373/clinchem.2019.302547. Epub 2019 May 15.
8
The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.心血管危险因素稳定门诊患者中N末端B型利钠肽原/ B型利钠肽的摩尔比与心力衰竭相关事件的关系
Intern Med. 2018 Sep 15;57(18):2621-2630. doi: 10.2169/internalmedicine.0471-17. Epub 2018 Apr 27.
9
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).体重指数对 N 末端 pro-B 型利钠肽与急性心力衰竭患者发病率和死亡率之间关系的影响:来自 ASCEND-HF(急性失代偿性心力衰竭中奈西立肽临床疗效的研究)的结果。
J Am Heart Assoc. 2018 Feb 3;7(3):e006740. doi: 10.1161/JAHA.117.006740.
10
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.联合应用氨基末端 pro-B 型利钠肽原和 B 型利钠肽对心力衰竭住院患者预后的评估。
Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28.

引用本文的文献

1
Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition.尽管有沙库巴曲缬沙坦抑制作用,中性肽链内切酶2仍催化利钠肽的降解。
Sci Rep. 2025 Jul 28;15(1):27401. doi: 10.1038/s41598-025-10166-z.
2
The Pathophysiology of Cardiac Troponin Release and the Various Circulating Cardiac Troponin Forms-Potential Clinical Implications.心肌肌钙蛋白释放的病理生理学及各种循环心肌肌钙蛋白形式——潜在的临床意义
J Clin Med. 2025 Jun 14;14(12):4241. doi: 10.3390/jcm14124241.
3
Identification of Proteomic Biomarkers of Acetaminophen-Induced Hepatotoxicity Using Stable Isotope Labeling.
采用稳定同位素标记技术鉴定对乙酰氨基酚诱导肝毒性的蛋白质组生物标志物。
Methods Mol Biol. 2024;2823:225-239. doi: 10.1007/978-1-0716-3922-1_14.
4
Biochemistry of the Endocrine Heart.内分泌心脏的生物化学
Biology (Basel). 2022 Jun 27;11(7):971. doi: 10.3390/biology11070971.